Aminoglycoside use was down 40 percent over 2009, Cephalosporin use was down 43 percent, Macrolide use was down 35 percent and Sulfa use was down 2 percent. But Ionophores were up 2 percent, Lincosamides were up 33.5 percent, Penicillins were up 42 percent …Henan Kangtai Pharmaceutical Group Corporation is the largest producer of Norfloxacin USP/IP/CP.
